Diatech Pharmacogenetics will attend the MEDICA Exhibition 2026

We are pleased to announce that we will be exhibiting at MEDICA again this year We look forward to see you in Düsseldorf, from 11 to 14 November. H01; Booth N.1B34 From 16 to 19 November 2026, MEDICA will once again gather international experts from the medical industry in Düsseldorf, Germany. With over 5,300 exhibitors […]

Diatech Pharmacogenetics joins the Human AI Foundation as a founding member

Connecting business and research to advance people-centred artificial intelligence. Oliva Alberti, CEO of Diatech Pharmacogenetics, serves as President.   Diatech Pharmacogenetics is a founding member of the Human AI Foundation, presented on 19 October 2026 at the University of Macerata, Italy. The initiative aims to help Italian businesses and organisations adopt artificial intelligence in ways […]

Diatech Pharmacogenetics tra i soci fondatori della Fondazione Human AI

Imprese e ricerca insieme per un’intelligenza artificiale al servizio delle persone. Alla presidenza Oliva Alberti, amministratore delegato di Diatech Pharmacogenetics. Diatech Pharmacogenetics è tra i soci fondatori della Fondazione Human AI, presentata il 19 ottobre 2026 all’Università di Macerata. L’iniziativa nasce per accompagnare le imprese e le organizzazioni italiane nell’adozione dell’intelligenza artificiale, valorizzando le competenze […]

Diatech Pharmacogenetics will attend the 16. Herbsttreffen der AG Molekularpathologie der DGP

Diatech Pharmacogenetics will participate in the 16th Autumn Meeting of the DGP Working Group on Molecular Pathology (16. Herbsttreffen der AG Molekularpathologie der DGP), taking place in Kiel, Germany, on 30 November and 1 December 2026. The event brings together experts in molecular pathology to discuss advances in molecular diagnostics, emerging technologies, and their integration […]

A Macerata la conferenza stampa di presentazione della Fondazione Human AI

Lunedì 19 ottobre 2026, presso l’Università di Macerata, sarà presentata ufficialmente la Fondazione Human AI, nata per promuovere un’adozione consapevole, etica e concreta dell’intelligenza artificiale nelle imprese e nella società. Alla guida della Fondazione, in qualità di Presidente, Oliva Alberti, Amministratore Delegato di Diatech Pharmacogenetics, contribuirà a delineare un percorso che mette al centro la […]

Intelligenza artificiale, democrazia, disuguaglianze

Lunedì 19 ottobre 2026, alle ore 10:00, presso la Loggia del Grano dell’Università di Macerata, si terrà l’incontro “Intelligenza artificiale, democrazia, disuguaglianze”, dedicato alle sfide etiche e sociali legate allo sviluppo dell’intelligenza artificiale. Tra gli interventi in programma, Oliva Alberti, Amministratore Delegato della Diatech Pharmacogenetics e Presidente della Fondazione Human AI, contribuirà al dibattito insieme […]

Diatech Pharmacogenetics will attend the APTAP Congress in Oeira

From October 8 to 10, Diatech Pharmacogenetics will participate as an exhibitor at the XXVI APTAP Congress in Oeiras, Portugal, bringing together professionals in Anatomical Pathology for three days of scientific exchange, innovation, and discussion. During the congress, Diatech will present its solutions for molecular diagnostics and precision medicine, connecting with professionals and exploring new […]

Diatech Pharmacogenetics will attend the SFMPP Congress in Paris

On October 7 and 8, Diatech Pharmacogenetics will participate as an exhibitor at the SFMCP Congress in Paris, bringing together professionals and experts in pathology, molecular diagnostics, and healthcare to share knowledge and discuss the latest developments in the field. Diatech’s participation highlights its commitment to supporting the evolution of molecular diagnostics and precision medicine. […]

Diatech Pharmacogenetics will attend the SEAP- IAP 2026

Diatech Pharmacogenetics will participate in the SEAP Congress 2026 in Córdoba, Spain, alongside its valuable partner Werfen, the company’s trusted distributor for Spain and Portugal. As one of the leading events for pathology in the Iberian Peninsula, the SEAP Congress brings together pathologists, laboratory professionals, and industry experts to explore the latest advances in diagnostic […]

Diatech Pharmacogenetics will attend the 38th European Congress of Pathology

Diatech Pharmacogenetics will participate as an exhibitor at the 38th European Congress of Pathology (ECP) in Stockholm, one of the world’s leading events for pathology and molecular diagnostics. The congress brings together pathologists, researchers, and healthcare professionals from across the globe to discuss the latest scientific advances and innovations shaping the future of precision medicine. […]

logo Diatech Pharmacogenetics

Subscribe to Our Newsletter

You are leaving the U.S. & Canada Research Use Only (RUO) area.

The content you are about to access is intended for other markets and may include products or information not available in the U.S. or Canada.

logo Diatech Pharmacogenetics
Select Your Region

Please select your region to access the content that is most relevant to your location and applicable regulations.